A randomized controlled trial of ergocalciferol 40,000 IU versus 100,000 IU/week for vitamin D inadequacy in postmenopausal women

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171122002

Enrollment

100

Registered

2017-11-22

Start date

2017-01-13

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post&#45

Interventions

vitaamin D2 40&#44

000 IU/week,vitamin D2 100&#44

000 IU/week

Active Comparator Drug,Active Comparator Drug

Vitamin D2 40&#44

Eligibility

Sex/Gender

Female

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Age > 60 years old Vitamin D inadequacy Nursing Home resident

Exclusion criteria

Exclusion criteria: Renal stone Hyperparathyroid Hypercalcemia

Design outcomes

Primary

Measure	Time frame
25 (OH) vitamin D level 12 weeks Electrochemiluminescence binding assay	—

Secondary

Measure	Time frame
Hand grip strength 12weeks Hand grip dynamometer	—

Countries

Thailand

Contacts

Public ContactPattranid Mueangpaisarn

geminii17@hotmail.com0818605793

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026

A randomized controlled trial of ergocalciferol 40&#44;000 IU versus 100&#44;000 IU/week for vitamin D inadequacy in postmenopausal women